Table 4 Multiple regression analysis within a linear mixed-effect model with EPO dose as dependent variable and other laboratory and clinical data entered
Variable | Estimate ± SE | p value |
|---|---|---|
(Intercept) | 110.2 ± 19.5 | <0.001 |
Hemoglobin | −3.3 ± 0.9 | <0.001 |
TSAT | −0.3 ± 0.1 | 0.004 |
Ferritin | −0.01 ± 0.0 | 0.01 |
Venofer treatment | 0.01 ± 0.01 | ns |
Calcium | −2.7 ± 1.8 | ns |
Phosphorus | −0.7 ± 0.8 | ns |
CVA | −3.7 ± 6.6 | ns |
Effect of time at 6 months | 0.13 ± 3.31 | ns |
Effect of time at 12 months | −7.50 ± 3.31 | 0.02 |
Effect of ergocalciferol at 6 months | 0.96 ± 4.36 | ns |
Effect of ergocalciferol at 12 months | −0.84 ± 4.35 | ns |